199 related articles for article (PubMed ID: 10665466)
1. Assessing clinical predictions of early rehospitalization in schizophrenia.
Olfson M; Mechanic D; Boyer CA; Hansell S; Walkup J; Weiden PJ
J Nerv Ment Dis; 1999 Dec; 187(12):721-9. PubMed ID: 10665466
[TBL] [Abstract][Full Text] [Related]
2. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.
Haywood TW; Kravitz HM; Grossman LS; Cavanaugh JL; Davis JM; Lewis DA
Am J Psychiatry; 1995 Jun; 152(6):856-61. PubMed ID: 7755114
[TBL] [Abstract][Full Text] [Related]
3. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
Hopko DR; Lachar D; Bailley SE; Varner RV
Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
[TBL] [Abstract][Full Text] [Related]
4. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.
Bodén R; Brandt L; Kieler H; Andersen M; Reutfors J
Schizophr Res; 2011 Dec; 133(1-3):36-41. PubMed ID: 21982098
[TBL] [Abstract][Full Text] [Related]
5. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
[TBL] [Abstract][Full Text] [Related]
8. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
9. Body mass index identified as an independent predictor of psychiatric readmission.
Manu P; Khan S; Radhakrishnan R; Russ MJ; Kane JM; Correll CU
J Clin Psychiatry; 2014 Jun; 75(6):e573-7. PubMed ID: 25004198
[TBL] [Abstract][Full Text] [Related]
10. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.
Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S
Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513
[TBL] [Abstract][Full Text] [Related]
11. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
Weinmann S; Janssen B; Gaebel W
J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
[TBL] [Abstract][Full Text] [Related]
12. Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders.
Ilgen MA; Hu KU; Moos RH; McKellar J
Psychiatr Serv; 2008 Sep; 59(9):982-8. PubMed ID: 18757590
[TBL] [Abstract][Full Text] [Related]
13. Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders.
Gao YN; Wang R; Gu G; Chung R; Olfson M
Schizophr Res; 2024 May; 267():165-172. PubMed ID: 38547719
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric readmissions and their association with physical comorbidity: a systematic literature review.
Šprah L; Dernovšek MZ; Wahlbeck K; Haaramo P
BMC Psychiatry; 2017 Jan; 17(1):2. PubMed ID: 28049441
[TBL] [Abstract][Full Text] [Related]
15. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.
Schwartz JE; Fennig S; Tanenberg-Karant M; Carlson G; Craig T; Galambos N; Lavelle J; Bromet EJ
Arch Gen Psychiatry; 2000 Jun; 57(6):593-600. PubMed ID: 10839338
[TBL] [Abstract][Full Text] [Related]
16. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
Conley RR; Love RC; Kelly DL; Bartko JJ
Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder.
Mueser KT; Yarnold PR; Bellack AS
Acta Psychiatr Scand; 1992 Jan; 85(1):48-55. PubMed ID: 1546548
[TBL] [Abstract][Full Text] [Related]
18. Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
Olfson M; Mechanic D; Hansell S; Boyer CA; Walkup J; Weiden PJ
Psychiatr Serv; 2000 Feb; 51(2):216-22. PubMed ID: 10655006
[TBL] [Abstract][Full Text] [Related]
19. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.
Hunt GE; Bergen J; Bashir M
Schizophr Res; 2002 Apr; 54(3):253-64. PubMed ID: 11950550
[TBL] [Abstract][Full Text] [Related]
20. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
Siris SG
Am J Psychiatry; 2000 Sep; 157(9):1379-89. PubMed ID: 10964850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
